PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
11.70%
Net income growth under 50% of AVGO's 36.67%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-1.75%
Negative yoy D&A while AVGO is 0.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-285.71%
Negative yoy deferred tax while AVGO stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-4.08%
Negative yoy SBC while AVGO is 16.67%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
148.85%
Slight usage while AVGO is negative at -65.00%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
84.57%
AR growth well above AVGO's 41.30%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
9.59%
Inventory shrinking or stable vs. AVGO's 50.00%, indicating lean supply management. David Dodd would confirm no demand shortfall.
100.00%
A yoy AP increase while AVGO is negative at -250.00%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
8100.00%
Some yoy usage while AVGO is negative at -91.67%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
No Data
No Data available this quarter, please select a different quarter.
134.52%
Operating cash flow growth above 1.5x AVGO's 19.13%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-39.93%
Both yoy lines negative, with AVGO at -22.22%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
1.63%
Purchases growth of 1.63% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-64.00%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-424.51%
Both yoy lines negative, with AVGO at -61.11%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-18.00%
Both yoy lines negative, with AVGO at -80.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
20.00%
Buyback growth of 20.00% while AVGO is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.